loadpatents
name:-0.14277100563049
name:-0.03232216835022
name:-0.00058388710021973
Diller; Dov Patent Filings

Diller; Dov

Patent Applications and Registrations

Patent applications and USPTO patent grants for Diller; Dov.The latest application filed is for "polymorphs of fexofenadine hydrochloride".

Company Profile
0.6.21
  • Diller; Dov - Jerusalem IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polymorphic Form XVI of fexofenadine hydrochloride
Grant 7,671,071 - Krochmal , et al. March 2, 2
2010-03-02
Polymorphs Of Fexofenadine Hydrochloride
App 20090149497 - DOLITZKY; Ben-Zion ;   et al.
2009-06-11
Polymorphic Form Xvi Of Fexofenadine Hydrochloride
App 20090054486 - Krochmal; Barnaba ;   et al.
2009-02-26
Polymorphs Of Fexofenadine Hydrochloride
App 20090012121 - DOLITZKY; Ben-Zion ;   et al.
2009-01-08
Methods of synthesizing olanzapine
Grant 7,425,627 - Dolitzky , et al. September 16, 2
2008-09-16
Polymorphs of solifenacin intermediate
App 20080114029 - Koltai; Tamas ;   et al.
2008-05-15
Crystal forms, methods for their preparation and method for preparation of olanzapine
Grant 7,323,459 - Dolitzky , et al. January 29, 2
2008-01-29
Preparation of risperidone
Grant 7,256,195 - Krochmal , et al. August 14, 2
2007-08-14
Novel crystal forms, methods for their preparation and method for preparation of olanzapine
App 20070129352 - Dolitzky; Ben Zion ;   et al.
2007-06-07
Process of synthesizing tadalafil
App 20060293331 - Dolitzky; Ben-Zion ;   et al.
2006-12-28
Preparation of tadalafil intermediates
App 20060276652 - Dolitzky; Ben-Zion ;   et al.
2006-12-07
Polymorphic form XVI of fexofenadine hydrochloride
App 20060217557 - Krochmal; Barnaba ;   et al.
2006-09-28
Synthesis of quetiapine and pharmaceutically acceptable salts thereof
Grant 7,071,331 - Diller , et al. July 4, 2
2006-07-04
Tadalafil crystal forms and processes for preparing them
App 20060111571 - Wizel; Shlomit ;   et al.
2006-05-25
Methods of synthesizing olanzapine
App 20050159408 - Dolitzky, Ben-Zion ;   et al.
2005-07-21
Preparation of risperidone
App 20040229905 - Krochmal, Barnaba ;   et al.
2004-11-18
Synthesis of quetiapine and pharmaceutically acceptable salts thereof
App 20040220400 - Diller, Dov ;   et al.
2004-11-04
Novel crystal forms, methods for their preparation and method for preparation of olanzapine
App 20040198721 - Dolitzky, Ben Zion ;   et al.
2004-10-07
Polymorphs of fexofenadine hydrochloride
App 20040167168 - Dolitzky, Ben-Zion ;   et al.
2004-08-26
Preparation of risperidone
Grant 6,750,341 - Krochmal , et al. June 15, 2
2004-06-15
Polymorphs of fexofenadine hydrochloride
App 20040058955 - Dolitzky, Ben-Zon ;   et al.
2004-03-25
Polymorphic form XVI of fexofenadine hydrochloride
App 20040044038 - Krochmal, Barnaba ;   et al.
2004-03-04
Polymorphs of fexofenadine base
App 20030158227 - Krochmal, Barnaba ;   et al.
2003-08-21
Polymorphs of fexofenadine hydrochloride
App 20030021849 - Dolitzky, Ben-Zion ;   et al.
2003-01-30
Polymorphs of fexofenadine hydrochloride
App 20020177608 - Dolitzky, Ben-Zion ;   et al.
2002-11-28
Preparation of risperidone
App 20020115672 - Krochmal, Barnaba ;   et al.
2002-08-22
Preparation of risperidone
App 20020115673 - Krochmal, Barnaba ;   et al.
2002-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed